GHK-Cu: A Copper Peptide Research Overview

The backstory on GHK-Cu is better than most of the hype written about it. At bottom it’s a copper complex of a dinky three-amino-acid peptide, glycyl-L-histidyl-L-lysine, the kind your own plasma carries and apparently loses as you get older. We’re going to stay close to the primary papers here: what the thing is, how it grabs copper, what the old cell experiments actually measured, and where that famous “it declines with age” line even comes from. Open any number below and you’ll find the paper behind it.

What GHK-Cu actually is

Strip the marketing off and GHK is three amino acids in a row: glycine, histidine, lysine. A tripeptide, nothing more. Add a copper(II) ion and you’ve got GHK-Cu. The peptide turned up as a growth-modulating factor in human plasma, and Pickart and Thaler’s 1980 work showed it associates with copper and iron in plasma and alters how cultured hepatoma cells grow and stick to surfaces [1]. The same study noted GHK bound copper, cobalt, iron, molybdenum, manganese, nickel and zinc at physiological pH, but had no affinity for calcium, potassium or sodium, with copper and iron the most active partners [1].

So right from the start people read it as a peptide that works as a metal chelate, not as some bare peptide drifting around on its own. Keep that in mind, because it colors everything that follows.

How it holds copper

The copper chemistry is where this molecule is genuinely well understood. Lau and Sarkar went at the Cu(II)-GHK interaction in 1981 with potentiometric titration and absorption spectrophotometry, traced which species exist from pH 3.5 to 10.6, and pinned down stability constants [2]. One nice detail: the amino group on the lysine side chain props up the complex’s stability, more so than you get with a shorter peptide like glycyl-L-histidine.

The eye-catching result from that paper: GHK can pull copper away from albumin. In equilibrium-dialysis experiments at equimolar peptide and albumin, roughly 42% of the Cu(II) ended up on the peptide [2]. At realistic physiological concentrations of copper, albumin, histidine and GHK, only about 6% sat on the low-molecular-weight components, which they read as a possible route for shuttling copper from blood toward tissue [2].

Decades later, Hureau and colleagues solved the X-ray structure and ran a battery of spectroscopies on Cu(II)-GHK [3]. Copper sits in a square-planar-ish arrangement bound by the N-terminal amine, a deprotonated backbone amide nitrogen and the histidine imidazole, with the fourth position taken by a labile oxygen. In the solid state the complex is a dimer; in solution it’s monomeric. They also found Cu(II)-GHK is redox-inert at moderate potentials but can be reduced to Cu(I) around -0.62 V, which then releases the copper [3]. A separate 2017 vibrational-spectroscopy study agreed on the copper coordination (N-terminus, amidate, histidine imidazole) and compared it with how the related DAHK sequence and zinc behave [6].

Property	Finding	Source
Sequence	Gly-His-Lys (tripeptide)	[1]
Copper ligands	N-terminus, backbone amide N, His imidazole	[3][6]
Copper vs albumin	~42% of Cu(II) held by GHK at equimolar levels	[2]
Solid-state form	Dimeric; monomeric in solution	[3]
Redox	Inert at moderate potential; reduced to Cu(I) near -0.62 V	[3]

What the early cell studies measured

The most cited bench result is Maquart and colleagues’ 1988 fibroblast work. Added to fibroblast cultures, GHK-Cu increased collagen synthesis. The effect started somewhere between 10^-12 and 10^-11 M, maxed out around 10^-9 M, and, importantly, happened without any change in cell number, so it wasn’t just more cells making more collagen [4]. The authors also pointed out that a GHK triplet appears in the alpha-2 chain of type I collagen, and floated the idea that proteases might liberate the tripeptide locally [4].

That’s a clean, specific, measurable finding, which is more than you can say for a lot of what gets written about this molecule. We’d flag the collagen result and the copper chemistry as the solid parts; much of the broader list of “actions” you see online comes from narrative reviews rather than controlled measurements.

The “declines with age” claim

You’ll see this everywhere: GHK in plasma falls with age, from around 200 ng/mL at 20 to about 80 ng/mL by 60. That figure traces back to Pickart’s review articles [5]. It’s worth being honest that this is a review-level number rather than something we can anchor to a single primary measurement in the sources we checked, so treat it as the commonly cited figure, not a hard constant.

The same reviews catalog a long list of proposed activities, from collagen and glycosaminoglycan synthesis to gene-expression modulation across thousands of genes [5][7]. Those reviews are useful maps of the field, but they’re summaries, not experiments. Where a claim rests on a review summarizing other work, we’ve said so rather than dressing it up as a measured result.

Characterizing GHK-Cu in the lab

As a small peptide-metal complex, GHK-Cu is identified the same way as any synthetic peptide: mass against the known structure, chromatographic purity, and, for the complex, confirmation that copper is actually coordinated. The spectroscopic signatures from the structural papers above give reference points for that [3][6]. For how purity testing and certificates of analysis work in general, see our write-up on third-party tested peptides, and batch documents live on our certificates of analysis page. If you want the broader context on how peptides like this are made and where their impurities come from, our piece on natural versus synthetic peptides covers it.

FAQ

What does the “Cu” in GHK-Cu mean?

It’s copper. GHK-Cu is the tripeptide glycyl-L-histidyl-L-lysine bound to a copper(II) ion, and the copper coordination is well characterized by X-ray and spectroscopy [2][3].

Where was GHK first found?

It was described as a growth-modulating factor isolated from human plasma, where it associates with copper and iron [1].

Is the collagen finding solid?

The 1988 fibroblast study measured increased collagen synthesis at low nanomolar and sub-nanomolar concentrations, independent of cell number, which makes it one of the better-defined results for this molecule [4].

References

1. Pickart L, Thaler MM. Growth-modulating tripeptide (glycylhistidyllysine): association with copper and iron in plasma, and stimulation of adhesiveness and growth of hepatoma cells in culture by tripeptide-metal ion complexes. J Cell Physiol. 1980. PMID 6246126
2. Lau SJ, Sarkar B. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma. Biochem J. 1981. PMID 7340824
3. Hureau C, Eury H, Guillot R, et al. X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties. Chemistry. 2011. PMID 21780203
4. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988. PMID 3169264
5. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015. PMID 26236730
6. Schirer A, et al. Similarities and differences of copper and zinc cations binding to biologically relevant peptides studied by vibrational spectroscopy. J Biol Inorg Chem. 2017. PMID 28321603
7. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018. PMID 29986520